Motor Oil Group CIO Nick Giannakakis interview: On digital transformation, Covid, and edge computing 23 Jun 2020
Xencor doses first patient in DUET-2 trial of XmAb20717 Xencor has dosed the first patient in the DUET-2 clinical trial, a Phase l trial... 16th July 2018